Literature DB >> 1336544

Expression of the p53 protein in a spectrum of astrocytic tumours.

D W Ellison1, K C Gatter, P V Steart, D P Lane, R O Weller.   

Abstract

Many human cancers are characterized by mutations of p53, a nuclear phosphoprotein which controls elements of the cell cycle. Turnover of p53 in normal cells is rapid, and the minute quantities of protein that are usually present are not detected by immunocytochemical methods. Mutations of the p53 gene in tumour cells are associated with a slower turnover and subsequent accumulation of the protein in both nucleus and cytoplasm. Genetic abnormalities of the short arm of chromosome 17, which is the site of the p53 gene locus, are a feature of astrocytic tumours. Using a panel of five antibodies to p53 and a standard immunocytochemical method, we found detectable quantities of p53 in the cells of 3/16 diffuse astrocytomas, 8/14 anaplastic astrocytomas, and 24/34 glioblastoma multiforme. Progression of one patient's tumour from a diffuse to an anaplastic astrocytoma was characterized by the accumulation of p53. The more malignant histological features of anaplastic astrocytoma and glioblastoma multiforme appear to be reflected by a greater incidence of p53 accumulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336544     DOI: 10.1002/path.1711680408

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia.

Authors:  Sarina Sulong; Abdul Aziz Mohamed Yusoff; Norafiza Zainuddin; Jafri Malin Abdullah; Jain George Pannatil; Hasnan Jaafar; Mohd Nizam Isa
Journal:  Malays J Med Sci       Date:  2004-01

2.  Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas.

Authors:  M Ohkoudo; H Sawa; M Hara; K Saruta; T Aiso; R Ohki; H Yamamoto; E Maemura; Y Shiina; M Fujii; I Saito
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

3.  Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.

Authors:  A Rathore; P Kamarajan; M Mathur; S Sinha; C Sarkar
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.

Authors:  H K Shu; M M Kim; P Chen; F Furman; C M Julin; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 5.  Genetics of primary brain tumors: a review.

Authors:  M Bondy; J Wiencke; M Wrensch; A P Kyritsis
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Increased hMSH2 protein expression in glioblastoma multiforme.

Authors:  Tapasya Srivastava; Parthaprasad Chattopadhyay; A K Mahapatra; Chitra Sarkar; Subrata Sinha
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

7.  Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

Authors:  D W Ellison; P V Steart; A C Bateman; R M Pickering; J D Palmer; R O Weller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

8.  p53 protein in low-grade astrocytomas: a study with long-term follow-up.

Authors:  P Iuzzolino; C Ghimenton; A Nicolato; F Giorgiutti; P Fina; C Doglioni; M Barbareschi
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.